These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 13661788)

  • 1. Severe toxic reactions associated with sulfamethoxypyridazine (kynex).
    SALVAGGIO J; GONZALEZ F
    Ann Intern Med; 1959 Jul; 51(1):60-7. PubMed ID: 13661788
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe reactions to long-acting sulfonamides. Erythema multiforme exudativum and lupus erythematosus following administration of sulfamethoxypyridazine and sulfadimethoxine.
    RALLISON ML; O'BRIEN J; GOOD RA
    Pediatrics; 1961 Dec; 28():908-17. PubMed ID: 14490042
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse reactions to sulfamethoxypyridazine (kynex); its use in the treatment of dermatitis herpetiformis.
    PERRY HO; WINKELMANN RK
    J Am Med Assoc; 1959 Jan; 169(2):127-32. PubMed ID: 13610642
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxic psychosis associated with sulfamethoxypyridazine (lederkyn).
    PAREKH JG; ADIGA ML
    Indian J Med Sci; 1958 Nov; 12(11):898-907. PubMed ID: 13610439
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous reactions due to sulfamethoxypyridazine.
    LINDSAY DG; PRLINA I; BISCHOFF AJ; BECKER SW
    AMA Arch Derm; 1958 Sep; 78(3):299-303. PubMed ID: 13570680
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and laboratory observations of sulfamethoxypyridazine (kynex) in urinary infections.
    HERROLD RD; KARABATSOS N
    J Urol; 1958 Jun; 79(6):1014-5. PubMed ID: 13540004
    [No Abstract]   [Full Text] [Related]  

  • 7. The prophylactic use of sulfamethoxypyridazine (kynex) during a streptococcal epidemic.
    SCHULTZ I; FRANK PF
    Am J Med Sci; 1958 Dec; 236(6):779-85. PubMed ID: 13606131
    [No Abstract]   [Full Text] [Related]  

  • 8. Stevens-Johnson syndrome following sulfame-thoxypyridazine (Kynex), treated successfully with triamcinolone.
    YAFFEE HS
    U S Armed Forces Med J; 1959 Dec; 10():1468-72. PubMed ID: 13846340
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythema multiforme exudativum associated with use of sulfamethoxypyridazine.
    COHLAN SQ
    J Am Med Assoc; 1960 Jun; 173():799-800. PubMed ID: 13811030
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythema multiforme associated with sulfamethoxypyridazine administration.
    Garner RC
    N Engl J Med; 1959 Dec; 261():1173-5. PubMed ID: 13826606
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental investigations of sulfamethoxypyridazine.
    ROEPKE RR; MAREN TH; MAYER E
    Ann N Y Acad Sci; 1957 Oct; 69(3):457-72. PubMed ID: 13488274
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism and binding of N-(2-methyl-6-methoxy-4-pyrimidinyl) sulfanilamide (sulfamethomidine) in man.
    DICARLO FJ; MALAMENT SG; HAYNES LJ; PHILLIPS GE
    Toxicol Appl Pharmacol; 1963 Jan; 5():61-70. PubMed ID: 14027680
    [No Abstract]   [Full Text] [Related]  

  • 13. Sulfamethoxypyridazine (Kynex), a new long-acting sulfonamide.
    BOGER WP; GYLFE JM; STRICKLAND CS
    Antibiotic Med Clin Ther (New York); 1956 Nov; 3(6):378-87. PubMed ID: 13363378
    [No Abstract]   [Full Text] [Related]  

  • 14. Sulfamethoxypyridazine and sulfachloropyridazine.
    JONES WF; FINLAND M
    Ann N Y Acad Sci; 1957 Oct; 69(3):473-84. PubMed ID: 13488275
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro susceptibility of Neisseria gonorrhoeae to the action of sulfamethoxypyridazine (kynex) and sulfadiazine.
    THAYER JD; FIELD FW; GARSON W
    Antibiot Chemother (Northfield); 1959 Mar; 9(3):176-9. PubMed ID: 24545155
    [No Abstract]   [Full Text] [Related]  

  • 16. Sulfamethoxypyridazine: pharmacological observations and clinical use in the treatment of urinary tract infections.
    JACKSON GG; GRIEBLE HG
    Ann N Y Acad Sci; 1957 Oct; 69(3):493-500. PubMed ID: 13488277
    [No Abstract]   [Full Text] [Related]  

  • 17. Sulfamethoxypyridazine in urinary tract infections.
    HARRIS AP; RILEY HD; KNIGHT V
    AMA Arch Intern Med; 1957 Nov; 100(5):701-8. PubMed ID: 13468814
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical experience with sulfamethoxypyridazine.
    WALKER WF; HAMBURGER M
    Ann N Y Acad Sci; 1957 Oct; 69(3):509-20. PubMed ID: 13488279
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of weekly oral doses of sulfamethoxypyridazine for rheumatic fever prevention.
    JOHNSON EE; MATHEWS MJ; STOLLERMAN GH
    J Pediatr; 1959 Apr; 54(4):468-73. PubMed ID: 13642220
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trial of a new long acting sulfonamide-sulfamethoxypyridazine.
    PAREKH JG; ADIGA ML; GOGATE AN; APTE NV
    Indian J Med Sci; 1958 Jun; 12(6):434-7. PubMed ID: 13574858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.